MNK-1411

· Mallinckrodt ARD LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNK-1411, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy [Phase 2]